Trilogy Metals (NYSEAMERICAN:TMQ) issued its quarterly earnings data on Tuesday. The mining company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.01), MarketWatch Earnings reports.
NYSEAMERICAN TMQ opened at $2.29 on Thursday. The stock has a market capitalization of $330.25 million, a price-to-earnings ratio of 2.14 and a beta of 1.55. Trilogy Metals has a 52-week low of $1.40 and a 52-week high of $2.60. The business’s 50-day moving average is $1.88.
Several equities analysts have issued reports on the company. Roth Capital raised their price objective on Trilogy Metals from $3.25 to $3.50 and gave the stock a “buy” rating in a report on Tuesday, February 16th. Zacks Investment Research raised Trilogy Metals from a “sell” rating to a “hold” rating in a report on Friday, December 25th. Raymond James raised their price target on Trilogy Metals from $3.75 to $4.00 and gave the stock an “outperform” rating in a report on Friday, January 15th. Finally, TD Securities raised their price target on Trilogy Metals from $3.25 to $3.50 and gave the stock a “hold” rating in a report on Tuesday, February 16th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $3.31.
Trilogy Metals Inc, a base metals exploration company, explores for and develops mineral properties in the United States. It principally holds interests in the Upper Kobuk mineral projects that include the Arctic, which contains polymetallic volcanogenic massive sulfide deposits; and Bornite that contains carbonate-hosted copper – cobalt deposits covering an area of approximately 426,690 acres located in the Ambler mining district in Northwest Alaska.
See Also: What is the Bid-Ask Spread?
Receive News & Ratings for Trilogy Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trilogy Metals and related companies with MarketBeat.com's FREE daily email newsletter.